Johnson & Johnson CFO on Q2 earnings beat

Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.

(Video length 00:03:55)

Joseph Wolk, Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.

 

STOCKS IN THIS ARTICLE

Comments